Is Royal Dutch Shell plc still a strong buy after Q3 results?

Bilaal Mohamed reviews today’s third-quarter results from Royal Dutch Shell plc (LON:RDSB).

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With the advent of electric vehicles, many believe the end is nigh for major oil producers such as BP and Royal Dutch Shell (LSE: RDSB). I’m certainly NOT one of them. In fact, I’m as bullish as ever on the future of oil. The Chinese and Indian economies are still growing at a blistering pace when compared to our own, and demand for the black stuff in these countries is actually growing.

Crude behaviour

With the price of a barrel of crude being so volatile over the past few years, it’s little wonder that many investors shun the oil & gas sector all together, but they do so at their peril. Even when Brent Crude was trading at below $30 per barrel, BP and Shell were still happy to reward shareholders handsomely just for owning their stock.

Earlier this week, London’s second largest oil major, BP, beat all expectations, announcing a doubling of profits to $1.87bn, together with a share buyback programme to offset the diluting effect of scrip dividends, which are paid in shares. As predicted, the quarterly dividend was held at 10¢ per share, thereby giving shareholders a mouth-watering 6% return.

Profits soar

Today it was Royal Dutch Shell’s turn to hit the headlines, and it didn’t disappoint. The Anglo-Dutch oil major saw its profits soar to $4.1bn during the three months to the end of September, well ahead of analyst’s consensus forecasts of $3.6bn, and a massive 47% higher than the $2.8bn posted for the same period in 2016.

CEO Ben van Beurden argued that the strong performance was further evidence of Shell’s growing momentum, and it strengthened his belief that the group’s strategy was working. And I would have to agree, with all three of Shell’s major businesses making resilient contributions to the strong results.

Plump yield

The group’s Upstream activities generated almost half of the $10bn cash flow from operations excluding working capital during the quarter, at an average Brent oil price of $52 per barrel. And this was complemented by good cash contributions from both Downstream activities and the growing Integrated Gas business.

Generating cash is particularly important for Shell, battling to maintain its enviable record of not having cut its dividend since the Second World War, while also paying off debts associated with the $50bn takeover of rival BG Group last year. With the oil price creeping up above $60 per barrel this week, its highest level in more than two years, to me the dividend looks safer than it has done for quite some time.

With the quarterly payout maintained at 47¢ per share, a rising oil price, and a more efficient business, I can’t see any reasons for income seekers to pass up on Shell’s plump 6% yield. So is the UK’s biggest oil company still a buy after these results? You betcha.

Bilaal Mohamed has no position in any shares mentioned. The Motley Fool UK has recommended BP and Royal Dutch Shell B. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Here’s 1 passive income stock yielding 10%+ today!

Zaven Boyrazian's on the hunt for high-yield income stocks that most investors are ignoring and has spotted one 10%-plus-yielding potential…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 7.1% forecast yield and 51% below ‘fair value’! 1 of my top FTSE stocks to buy right now

This FTSE giant is rarely seen as one of the obvious stocks to buy for dividend and price gains, but…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

£20,000 invested in HSBC shares 2 years ago is now worth…

HSBC shares have doubled in two years — but with key profitability targets raised, the latest numbers hint the real…

Read more »

A multiracial family of four, a mother, father and their two little boys on a staycation in the city of Newcastle on a sunny winters day
Investing Articles

No savings in your 40s? Start drip feeding £500 a month into UK shares in an ISA to aim for financial freedom

Got nothing in the bank and worried about retirement? Zaven Boyrazian explains how investing in UK shares today could help…

Read more »

Smartly dressed middle-aged black gentleman working at his desk
Investing Articles

Consider these FTSE 100 bargain shares in a Stocks and Shares ISA!

These FTSE 100 shares are trading on rock-bottom P/E and PEG ratios. Royston Wild explains what makes them stunning value…

Read more »

Artillery rocket system aimed to the sky and soldiers at sunset.
Investing Articles

This storming penny stock has already climbed nearly 50% in 2026!

Here's a penny stock that's been taking the defence sector by storm, and its future order book is building up…

Read more »

UK supporters with flag
Investing Articles

Should I buy this ridiculously cheap FTSE 250 stock today?

This FTSE 250 stock has one of the lowest P/E ratios in the index despite profits and margins surging higher.…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

57% under ‘fair value’ and 74% forecast earnings growth! 1 FTSE high-tech med stock I just can’t pass up

This FTSE high‑tech innovator’s earnings look set to soar -- yet it’s still priced as a risky biotech. The disconnect…

Read more »